154 related articles for article (PubMed ID: 11082993)
1. [Biochemical mechanism of raloxifen and tamoxifen action for the prevention of breast cancer. Studies in vitro].
Wołczyński S; Swiatecka J; Anchim T; Dabrowska M; Dziecioł J
Ginekol Pol; 2000 Sep; 71(9):1147-52. PubMed ID: 11082993
[TBL] [Abstract][Full Text] [Related]
2. Influence of estrogen, antiestrogen and UV-light on the balance between proliferation and apoptosis in MCF-7 breast adenocarcinoma cells culture.
Swiatecka J; Dziecioł J; Anchim T; Dabrowska M; Pietruczuk M; Wołczyński S
Neoplasma; 2000; 47(1):15-24. PubMed ID: 10870682
[TBL] [Abstract][Full Text] [Related]
3. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
Pickar JH; Komm BS
Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
[TBL] [Abstract][Full Text] [Related]
4. [Specific estrogen receptor modulators (SERMs)].
Trémollières F; Lopes P
Presse Med; 2002 Sep; 31(28):1323-8. PubMed ID: 12355995
[TBL] [Abstract][Full Text] [Related]
5. Progress in the prevention of breast cancer: concept to reality.
Jordan VC
J Steroid Biochem Mol Biol; 2000 Nov; 74(5):269-77. PubMed ID: 11162935
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer chemoprevention: a review of selective estrogen receptor modulators.
Johansen AM
Clin J Oncol Nurs; 2005 Jun; 9(3):317-20. PubMed ID: 15973842
[TBL] [Abstract][Full Text] [Related]
7. Role of raloxifene in breast cancer prevention in postmenopausal women: clinical evidence and potential mechanisms of action.
Sporn MB; Dowsett SA; Mershon J; Bryant HU
Clin Ther; 2004 Jun; 26(6):830-40. PubMed ID: 15262454
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen prevention of breast cancer: an instance of the fingerpost.
Lippman SM; Brown PH
J Natl Cancer Inst; 1999 Nov; 91(21):1809-19. PubMed ID: 10547388
[No Abstract] [Full Text] [Related]
9. Raloxifene in breast cancer prevention.
Gennari L; Merlotti D; Paola VD; Nuti R
Expert Opin Drug Saf; 2008 May; 7(3):259-70. PubMed ID: 18462184
[TBL] [Abstract][Full Text] [Related]
10. The selective oestrogen receptor modulators idoxifene and raloxifene have fundamentally different cell-specific oestrogen-response element (ERE)-dependent/independent mechanisms in vitro.
Nuttall ME; Fisher PW; Suva LJ; Gowen M
Eur J Cancer; 2000 Sep; 36 Suppl 4():S63-4. PubMed ID: 11056323
[TBL] [Abstract][Full Text] [Related]
11. Selective estrogen receptor (ER) modulators differentially regulate phospholipase D catalytic activity in ER-negative breast cancer cells.
Eisen SF; Brown HA
Mol Pharmacol; 2002 Oct; 62(4):911-20. PubMed ID: 12237338
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells.
Wang Z; Kyo S; Maida Y; Takakura M; Tanaka M; Yatabe N; Kanaya T; Nakamura M; Koike K; Hisamoto K; Ohmichi M; Inoue M
Oncogene; 2002 May; 21(22):3517-24. PubMed ID: 12032853
[TBL] [Abstract][Full Text] [Related]
13. The selective estrogen receptor modulators in breast cancer prevention.
Li F; Dou J; Wei L; Li S; Liu J
Cancer Chemother Pharmacol; 2016 May; 77(5):895-903. PubMed ID: 26787504
[TBL] [Abstract][Full Text] [Related]
14. Selective estrogen receptor modulators and prevention of invasive breast cancer.
Gradishar WJ; Cella D
JAMA; 2006 Jun; 295(23):2784-6. PubMed ID: 16754726
[No Abstract] [Full Text] [Related]
15. In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer.
Taras TL; Wurz GT; DeGregorio MW
J Steroid Biochem Mol Biol; 2001 Jun; 77(4-5):271-9. PubMed ID: 11457665
[TBL] [Abstract][Full Text] [Related]
16. Tumor growth inhibition, apoptosis, and Bcl-2 down-regulation of MCF-7ras tumors by sodium phenylacetate and tamoxifen combination.
Adam L; Crépin M; Isräel L
Cancer Res; 1997 Mar; 57(6):1023-9. PubMed ID: 9067263
[TBL] [Abstract][Full Text] [Related]
17. Effect of SERMs on breast tissue.
Goldstein SR
J Endocrinol Invest; 1999 Sep; 22(8):636-40. PubMed ID: 10532251
[No Abstract] [Full Text] [Related]
18. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
19. Estrogen-mediated mechanisms to control the growth and apoptosis of breast cancer cells: a translational research success story.
McDaniel RE; Maximov PY; Jordan VC
Vitam Horm; 2013; 93():1-49. PubMed ID: 23810002
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of breast cancer.
O'Regan RM; Jordan VC
Cancer Treat Res; 2001; 106():137-54. PubMed ID: 11225001
[No Abstract] [Full Text] [Related]
[Next] [New Search]
